1022.2000 19.90 (1.99%)
NSE Jul 10, 2025 15:31 PM
Volume: 59,260
 

1022.20
1.99%
BOB Capital Markets Ltd.
Q4 revenue of Rs 6.2bn (+21% YoY) beat our estimate by 14% driven by recovery in CDMO and growth in API
Alivus Life Sciences Ltd. is trading below its 50 day SMA of 1054.8
More from Alivus Life Sciences Ltd.
Recommended